patritumab,ruxolitinib
amgen,daiichi sankyo,novartis,incyte
['breast', 'patritumab', 'her3-dxd', 'bcsm', 'rux,(-crux),(-trux)']
our #asco23 star presenting results of a phase ii trial investigating #patritumabderuxtecan (her3-dxd) in heavily pretreated patients with her2-negative advanced #breastcancer: very promising data! #bcsm 
Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Chair of @myESMO YOC. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.